Nanostructure, Excitations, and Thermoelectric Properties of Bi2Te3-Based Nanomaterials

in Journal of Electronic Materials (2012), 41(6), 1792-1798

The effect of dimensionality and nanostructure on thermoelectric properties in Bi2Te3-based nanomaterials is summarized. Stoichiometric single-crystalline Bi2Te3 nanowires were prepared by potential ... [more ▼]

The effect of dimensionality and nanostructure on thermoelectric properties in Bi2Te3-based nanomaterials is summarized. Stoichiometric single-crystalline Bi2Te3 nanowires were prepared by potential-pulsed electrochemical deposition in a nanostructured Al2O3 matrix, yielding transport in the basal plane. Polycrystalline, textured Sb2Te3 and Bi2Te3 thin films were grown at room temperature using molecular beam epitaxy and subsequently annealed at 250A degrees C. Sb2Te3 films revealed low charge carrier density of 2.6 x 10(19) cm(-3), large thermopower of 130 V K-1, and large charge carrier mobility of 402 cm(2) V-1 s(-1). Bi-2(Te0.91Se0.09)(3) and (Bi0.26Sb0.74)(2)Te-3 nanostructured bulk samples were prepared from as-cast materials by ball milling and subsequent spark plasma sintering, yielding grain sizes of 50 nm and thermal diffusivities reduced by 60\%. Structure, chemical composition, as well as electronic and phononic excitations were investigated by x-ray and electron diffraction, nuclear resonance scattering, and analytical energy-filtered transmission electron microscopy. calculations yielded point defect energies, excitation spectra, and band structure. Mechanisms limiting the thermoelectric figure of merit for Bi2Te3 nanomaterials are discussed. [less ▲]

51. Telmisartan Plus HCTZ vs. Amlodipine Plus HCTZ in older patients with systolic hypertension : results from a large ambulatory blood pressure monitoring study

in American Journal of Geriatric Cardiology (2006), 15

Systolic hypertension often requires combination therapy. Few data exist comparing angiotensin receptor blocker plus diuretic therapy with other combinations in older patients. In a prospective ... [more ▼]

Systolic hypertension often requires combination therapy. Few data exist comparing angiotensin receptor blocker plus diuretic therapy with other combinations in older patients. In a prospective, randomized, open-label, blinded-end point trial, patients (≥60 years of age) with predominantly systolic hypertension received telmisartan 40–80 mg or amlodipine 5–10 mg for 8 weeks, before the addition of hydrochlorothiazide (HCTZ) 12.5 mg for a further 6 weeks. Twenty-four-hour ambulatory blood pressure monitoring showed that telmisartan plus HCTZ (n =448) and amlodipine plus HCTZ (n =424) changed systolic blood pressure for the last 6 hours of the dosing interval by −18.3 and −17.4 mm Hg, respectively (p =0.2520). Over the 24-hour period, telmisartan plus HCTZ was superior (−19.3 and −17.2 mm Hg, respectively; p =0.001) and provided higher systolic control rates (65.9% and 58.3%, respectively; p =0.0175). Adverse events (41.2% and 53.7%, respectively) and discontinuations (5.0% and 11.3%, respectively) were lower (p<0.0001) with telmisartan than with amlodipine, mainly due to peripheral edema (1.2% and 24.3%, respectively). [less ▲]